Various pharmaceutical products / 2024-2025
Buyer: Terveyden ja hyvinvoinnin laitos
- Published
- 29 October 2024
- Procedure
- Open procedure
- Notice number
- 00655928-2024
- Reference
- 8d70c6eb-56cb-45e9-8d7a-24eef6b390fb
- Official source
- Official source
CPV codes
- 33600000Productos farmacéuticos
Description
Finnish Institute for Health and Welfare, later referred to as THL or Customer, requested tenders for Various pharmaceutical products to the rescEU project. The Scope of procurement is described in more detail in Annex 1 to the Call for tenders. The procurement is divided in fifteen (15) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots. - LOT 1: Morphine 10-20 mg/ml (1-5 ml per vial/ampoule, i.m., ATC N02AA01) - LOT 2: Ondansetron 2 mg/ml (2-4 ml per vial/ampoule, i.m. and i.v., ATC A04AA01) - LOT 3: Ondansetron 4-8 mg per tablet/capsule, oral (ATC A04AA01) - LOT 4: Hydrocortisone 250 mg / 2 ml (2 ml per vial/ampoule i.v., ATC H02AB09) - LOT 5: Epinephrine (Adrenaline) 1 mg/ml (1-5 ml per vial/ampoule, i.v. and i.m., ATC C01CA24) - LOT 6: Diazepam 10 mg / 2 ml (2 ml per vial/ampoule, i.m. and i.v., ATC N05BA01) - LOT 7: Midazolam 1-5 mg/ml (3-10 ml per vial/ampoule, i.v., ATC N05CD08) - LOT 8: Salbutamol 200 µg/dose (inhaler, 60 or 200 doses, ATC R03AC02) - LOT 9: Budesonide 0,5 mg/ml (2 ml nebuliser suspension per respule, ATC R03BA02) - LOT 10: Ciprofloxacin 2 mg/ml (100-200 ml per vial/ampoule, i.v., ATC J01MA02) - LOT 11: Strepto…
Lots (15)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | LOT 1: Morphine 10-20 mg/ml (1-5 ml per vial/ampoule, i.m., ATC N02AA01) | 33600000 Productos farmacéuticos | — |
| 2 | LOT 2: Ondansetron 2 mg/ml (2-4 ml per vial/ampoule, i.m. and i.v., ATC A04AA01) | 33600000 Productos farmacéuticos | — |
| 3 | LOT 3: Ondansetron 4-8 mg per tablet/capsule, oral (ATC A04AA01) | 33600000 Productos farmacéuticos | — |
| 4 | LOT 4: Hydrocortisone 250 mg / 2 ml (2 ml per vial/ampoule i.v., ATC H02AB09) | 33600000 Productos farmacéuticos | — |
| 5 | LOT 5: Epinephrine (Adrenaline) 1 mg/ml (1-5 ml per vial/ampoule, i.v. and i.m., ATC C01CA24) | 33600000 Productos farmacéuticos | — |
| 6 | LOT 6: Diazepam 10 mg / 2 ml (2 ml per vial/ampoule, i.m. and i.v., ATC N05BA01) | 33600000 Productos farmacéuticos | — |
| 7 | LOT 7: Midazolam 1-5 mg/ml (3-10 ml per vial/ampoule, i.v., ATC N05CD08) | 33600000 Productos farmacéuticos | — |
| 8 | LOT 8: Salbutamol 200 µg/dose (inhaler, 60 or 200 doses, ATC R03AC02) | 33600000 Productos farmacéuticos | — |
| 9 | LOT 9: Budesonide 0,5 mg/ml (2 ml nebuliser suspension per respule, ATC R03BA02) | 33600000 Productos farmacéuticos | — |
| 10 | LOT 10: Ciprofloxacin 2 mg/ml (100-200 ml per vial/ampoule, i.v., ATC J01MA02) | 33600000 Productos farmacéuticos | — |
| 11 | LOT 11: Streptomycin 1 g per vial/ampoule, i.m. (ATC J01GA01) | 33600000 Productos farmacéuticos | — |
| 12 | LOT 12: Meropenem 500-1000 mg per vial/ampoule, i.v. (ATC J01DH02) | 33600000 Productos farmacéuticos | — |
| 13 | LOT 13: Clindamycin 600 mg / 4 ml (4 ml per vial/ampoule, i.m. and i.v., ATC J01FF01) | 33600000 Productos farmacéuticos | — |
| 14 | LOT 14: Ciprofloxacin 250-500 mg per tablet/capsule, oral (ATC J01MA02) | 33600000 Productos farmacéuticos | — |
| 15 | LOT 15: Ethanol 95-96 % (5-20 ml per vial/ampoule, i.v., ATC V03AB16) | 33600000 Productos farmacéuticos | — |
Award criteria
- Price — Enter the total price of the offered Articles. The total price shall be based on the quantity of single units (vial/ampoule) that is needed to comply with the announced active pharmaceutical…
- Price — Enter the total price of the offered Articles. The total price shall be based on the quantity of single units (vial/ampoule) that is needed to comply with the announced active pharmaceutical…
- Price — Enter the total price of the offered Articles. The total price shall be based on the quantity of single units (vial/ampoule) that is needed to comply with the announced active pharmaceutical…
- Price — Enter the total price of the offered Articles. The total price shall be based on the quantity of single units (vial/ampoule) that is needed to comply with the announced active pharmaceutical…
- Price — Enter the total price of the offered Articles. The total price shall be based on the quantity of single units (vial/ampoule) that is needed to comply with the announced active pharmaceutical…
- Price — Enter the total price of the offered Articles. The total price shall be based on the quantity of single units (vial/ampoule) that is needed to comply with the announced active pharmaceutical…
- Price — Enter the total price of the offered Articles. The total price shall be based on the quantity of single units (vial/ampoule) that is needed to comply with the announced active pharmaceutical…
- Price — Enter the total price of the offered Articles. The total price shall be based on the quantity of single units (vial/ampoule) that is needed to comply with the announced active pharmaceutical…
- Price — Enter the total price of the offered Articles. The total price shall be based on the quantity of single units (vial/ampoule) that is needed to comply with the announced active pharmaceutical…
- Price — Enter the total price of the offered Articles. The total price shall be based on the quantity of single units (vial/ampoule) that is needed to comply with the announced active pharmaceutical…
- Price — Enter the total price of the offered Articles. The total price shall be based on the quantity of single units (vial/ampoule) that is needed to comply with the announced active pharmaceutical…
- Quality — The offered Article has as long as possible registered shelf life. Shelf life of 3 years (36 months) or more receives 30 points. Shelf life less than 3 years (36 months) receives 0 point.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| FrostPharma AB | €3,600,000 | — |
| FrostPharma AB | €1,029,000 | — |
| Orion Oyj | €184,000 | — |
| FrostPharma AB | €158,760 | — |
| FrostPharma AB | €150,000 | — |
| Pfizer Oy | €94,160 | — |
| Grindeks Kalceks Suomi Oy | €31,200 | — |
| Grindeks Kalceks Suomi Oy | €30,240 | — |
| Fresenius Kabi Ab | €28,140 | — |
| Grindeks Kalceks Suomi Oy | €23,000 | — |
Official publications
- TED · 00655928-2024 · 29 October 2024
- OJS · 211/2024 · 29 October 2024
Other tenders from Terveyden ja hyvinvoinnin laitos
- Sanastotyön asiantuntijapalvelut
- Laskutuksen toiminnanohjausjärjestelmä
- Azithromycin oral suspension 40 mg/ml - SUSPENDED
- WGS kirjastokitit
- THL - Luokka 2 - Viestintä- ja markkinointipalvelut 2020-2026 (DPS) - Tapahtumahallintajärjestelmä
- Olosuhdevalvontajärjestelmä
- Huoltosopimus laitteelle ABI3500XL ja vuosihuolto laitteelle ABI3500
- Tietoturvallisuuden arviointi- ja konsultointipalvelut (puitejärjestely)
- Clindamycin 150 mg/ml (4ml per vial/ampoule)
- Nextera XT Library Preparation Kit
Frequently asked questions
- Who is the buyer of this tender?
- The contracting authority is Terveyden ja hyvinvoinnin laitos (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Create a free account and receive new tenders from European Union matching your business, every day.